Berlin [Germany], December 1 (ANI/Sputnik): German BioNTech biopharmaceutical company and its US partner Pfizer have submitted a formal application to register their vaccine against coronavirus in the European Union which, if approved, will allow EU nations to start vaccinating their populat
Washington [US], November 20 (ANI): American drug giant Pfizer and German laboratory BioNTech on Friday said that they will be submitting to the US Food and Drug Administration for emergency use authorisation for their COVID-19 vaccine candidate.
Rio de Janeiro [Brazil], November 19 (ANI/Sputnik): Pharmaceutical company Pfizer and German laboratory BioNTech have proposed a plan for the Brazilian government on vaccination against the novel coronavirus disease (COVID-19) in the first half of 2021, the companies said in a statement.
Washington [US], November 18 (ANI): American drug giant Pfizer on Wednesday said that final results from the late-stage trial of its coronavirus vaccine was found to be 95 per cent effective and had no serious side effects on older people.
Berlin [Germany], November 14 (ANI/Sputnik): German BioNTech biopharmaceutical company that had teamed up with US Pfizer for the development of a vaccine against Covid-19, told Sputnik on Friday that it had not yet received the information as to when vaccination will start in Germany
New Delhi [India], November 10 (ANI): A day after Pfizer Inc and BioNTech SE announced around 90 per cent efficacy of their COVID-19 vaccine in their ongoing phase three trial, the central government on Tuesday said that it is in dialogue with both the domestic and international vaccine manu
Washington [US], November 9 (ANI): The coronavirus vaccine developed by drug giant American Pfizer and German biotechnology firm BioNTech was more than 90 per cent effective at protecting people from infection as compared to placebo saline shot, according to an analysis.
Canberra [Australia], November 5 (ANI/Sputnik): The Australian government has signed agreements on Thursday with pharmaceutical company Novavax and a consortium of companies, Pfizer and BioNTech, to supply 50 million doses of COVID-19 vaccines.
London [UK], September 10 (ANI/Sputnik): AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 or early 2021, despite having to pause clinical trials.
Washington D.C. [US], July 23 (ANI): The U.S. has agreed to pay Pfizer and BioNTech SE nearly $2 billion to secure 100 million doses of their experimental Covid-19 vaccine to provide to Americans free of charge, reported The Wall Street Journal.
Mumbai (Maharashtra) [India], July 2 (ANI): Equity benchmark indices were up by nearly one per cent during early hours on Thursday tracking gains in Asian peers as investors hoped of a vaccine for COVID-19.